通过向Bcl-2来释放树突细胞介导的瘤清除
1Molecular Cell Biology Laboratory, Department of Genetics, The Smurfit Institute, Trinity College, Dublin 2, Ireland.
Trends in immunology
|October 9, 2023
概括
小分子Bcl-2-对抗剂,称为BH3模仿剂,不仅向癌细胞,而且意外地激活树突细胞 (DC). 这种激活使免疫系统为T细胞介导的瘤清除做准备,提供了一种新的治疗策略.
科学领域:
- 在瘤学瘤学.
- 免疫学 免疫学 免疫学
- 分子生物学分子生物学
背景情况:
- Bcl-2家族蛋白调节细胞亡,在各种癌症中经常过度表达.
- 小分子Bcl-2-对抗剂 (BH3模仿剂) 是已建立的向癌症治疗方法.
- 精确的BH3模仿剂的免疫调节作用仍然是积极研究的领域.
研究的目的:
- 为了研究BH3模仿物的潜在免疫调节作用,超出其直接的抗癌活性.
- 确定BH3模仿剂是否可以影响免疫细胞,特别是树突细胞 (DC) 的功能.
- 探索BH3模仿剂对抗瘤免疫的DC激活的影响.
主要方法:
- 在临床前癌症模型中利用小分子BH3模仿剂.
- 在用BH3模仿剂治疗时,评估了树突细胞 (DC) 的激活状态和功能.
- 评估了BH3模拟处理的DCs对T细胞进行抗瘤反应的能力.
主要成果:
- BH3仿真体显示出一种意想不到的激活树突细胞 (DC) 的能力.
- 激活的直流细胞表现出对T细胞的增强能力.
- 这种DC启动的T细胞反应在临床前模型中有助于瘤清除.
结论:
- BH3模仿剂具有双重的作用机制,向癌细胞并调节免疫系统.
- 通过BH3模仿剂的DC激活代表了增强T细胞介导抗瘤免疫力的新途径.
- 这些发现表明,BH3模仿剂可以作为癌症治疗的免疫治疗剂.
更多相关视频
相关概念视频
Cytotoxic T Cells-mediated Immune Response
951
Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
951
Tumor Immunotherapy
539
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
539
Targeted Cancer Therapies
7.7K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.7K
T Cell Activation and Clonal Selection
774
T cells are integral to our adaptive immune system, recognizing and effectively responding to foreign antigens. T cell activation and clonal selection are pivotal in orchestrating this immune response. This article elucidates these mechanisms, detailing the roles of cluster of differentiation (CD) markers, major histocompatibility complex (MHC) molecules, costimulatory signals, and the process of clonal selection.
Naive T cells that have not yet encountered an antigen express two primary CD...
Naive T cells that have not yet encountered an antigen express two primary CD...
774


